EFFECTS OF BIOLOGICAL-DMARDS ON THE SERUM URIC ACID LEVEL IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Miwa, Y. [1 ,2 ]
Miwa, Y. [1 ,2 ]
机构：
[1] Showa Univ, Div Rheumatol, Dept Med, Sch Med, Yokohama, Japan
[2] Showa Univ, Dept Nursing, Sch Nursing & Rehabil Sci, Yokohama, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Rheumatoid arthritis;
D O I：
10.1136/annrheumdis-2023-eular.1818
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0328
引用
收藏
页码：1347 / 1347
页数：1
相关论文
共 50 条
  • [41] Risk for infections with glucocorticoids and DMARDs in patients with rheumatoid arthritis
    Riley, Thomas R.
    George, Michael D.
    RMD OPEN, 2021, 7 (01):
  • [42] EFFECT OF PHENYLBUTAZONE ON URIC ACID EXCRETION IN PATIENTS WITH GOUT AND RHEUMATOID ARTHRITIS
    BISHOP, C
    BEECHER, L
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1953, 83 (03): : 603 - 605
  • [43] SERUM FOLIC ACID LEVEL AND HEPATOTOXICITY OF METHOTREXATE IN RHEUMATOID ARTHRITIS
    Dordevic, T.
    Madic, S.
    Ilic, M.
    Stanojkovic, M.
    Kundalic, S.
    Ristic, T.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S819 - S819
  • [44] RELATIONSHIP BETWEEN BIOLOGICAL DMARDS TREATMENT AND COMPLICATIONS AFTER SURGICAL TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Hirano, Y.
    Hirabara, S.
    Isono, M.
    Ishiguro, N.
    Kojima, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 483 - 484
  • [45] Intensive Intervention Can Lead to a Treatment Holiday from Biological DMARDs in Patients with Rheumatoid Arthritis
    Tanaka, Yoshiya
    Hirata, Shintaro
    DRUGS, 2014, 74 (18) : 2129 - 2139
  • [46] SURVIVAL ANALYSIS OF BIOLOGICAL DMARDS AND JAK INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS REQUIRING SWITCHING OF TREATMENT
    Bobkova, A. O.
    Glukhova, S. I.
    Karateev, A. E.
    Potapova, A. S.
    Lila, A. M.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S149 - S150
  • [47] COMPARISON OF TOFACITINIB SAFETY AND EFFICACY IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS, OR TO ONE OR MORE BIOLOGICAL DMARDS
    Charles-Schoeman, C.
    Kremer, J.
    Krishnaswami, S.
    Soma, K.
    Geier, J.
    Zhang, R.
    Strengholt, S.
    Burmester, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 271 - 272
  • [48] Upadacitinib in Patients with Rheumatoid Arthritis and Inadequate Response or Intolerance to Biological DMARDs: Results at 60 Weeks
    Genovese, Mark
    Combe, Bernard
    Hall, Stephen
    Rubbert-Roth, Andrea
    Zhong, Sheng
    Meerwein, Sebastian
    Pangan, Aileen
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [49] Doppler ultrasound predicts successful discontinuation of biological DMARDs in rheumatoid arthritis patients in clinical remission
    Terslev, Lene
    Brahe, Cecilie Heegaard
    Hetland, Merete Lund
    Georgiadis, Stylianos
    Ellegaard, Karen
    Juul, Lars
    Tuan Huynh
    Dohn, Uffe Moller
    Fana, Viktoria
    Moller, Torsten
    Krabbe, Simon
    Ornbjerg, Lykke Midtboll
    Glinatsi, Daniel
    Rogind, Henrik
    Hansen, Anette
    Norregaard, Jesper
    Jacobsen, Soren
    Jensen, Dorte Vendelbo
    Manilo, Natalia
    Asmussen, Karsten
    Boesen, Mikael
    Rastiemadabadi, Zoreh
    Morsel-Carlsen, Lone
    Moller, Jakob Mollenbach
    Krogh, Niels Steen
    Ostergaard, Mikkel
    RHEUMATOLOGY, 2021, 60 (12) : 5549 - 5559
  • [50] Uric acid and cardiovascular risk in rheumatoid arthritis
    Daoussis, Dimitrios
    Kitas, George D.
    RHEUMATOLOGY, 2011, 50 (08) : 1354 - 1355
12345